Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line

被引:0
|
作者
Okamura, Masahiko
Kobayashi, Masaki
Suzuki, Fumika
Shimada, Jun
Sakagami, Hiroshi [1 ]
机构
[1] Meikai Univ, Dept Diagnost & Therapeut Sci, Div Pharmacol, Sch Dent, Sakado, Saitama 3500283, Japan
[2] Meikai Univ, Dept Diagnost & Therapeut Sci, Div Oral Maxillofacial Surg, Sch Dent, Sakado, Saitama 3500283, Japan
关键词
cisplatin; 5-fluorouracil; chemotherapy; cytotoxicity; combination effect; oral squamous cell carcinoma; polyamine; HSC-2; TUMOR-CELLS; HL-60; CELLS; INTRACELLULAR CONCENTRATIONS; IN-VIVO; APOPTOSIS; CANCER; HEAD; NECK; POLYAMINES; RECURRENT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The possible apoptosis-inducing activity of several sequential treatments of cisplatin (CDDP) and 5-fluorouracil (5-FU) against the human oral squamous cell carcinoma HSC-2 cell line was investigated. The following three combination treatments (CT) were used: simultaneous treatment with CDDP and 5-FU (for 72 hours) (CT-1), CDDP treatment (24 hours) followed by 5-FU treatment (48 hours) (CT-2) and 5-FU treatment (24 hours) followed by CDDP treatment (48 hours) (CT-3). CT-1 produced the highest cytotoxicity, followed by CT-3 and CT-2. No treatment induced any detectable internucleosomal DNA fragmentation, and caspase-3,-8 and -9 were activated to a much lesser extent than that attained using actinomycin D. High-performance liquid chromatography analysis demonstrated that 5-FU, as well as CT-1 and CT-2, preferentially reduced the intracellular concentration of putrescine. These results suggest that simultaneous treatment with CDDP and 5-FU induces lower level of apoptotic cell death in HSC-2 cells.
引用
收藏
页码:3331 / 3337
页数:7
相关论文
共 50 条
  • [1] Induction of Immunogenic Cell Death of Esophageal Squamous Cell Carcinoma by 5-Fluorouracil and Cisplatin
    Nishimura, Junya
    Deguchi, Sota
    Tanaka, Hiroaki
    Yamakoshi, Yoshihito
    Yoshii, Mami
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Lee, Shigeru
    Muguruma, Kazuya
    Ohira, Masaichi
    IN VIVO, 2021, 35 (02): : 743 - 752
  • [2] Chemosensitivity of cisplatin and 5-fluorouracil on oral squamous cell carcinoma cell lines
    Lee, JH
    Kim, MJ
    JOURNAL OF DENTAL RESEARCH, 1998, 77 (05) : 1318 - 1318
  • [3] Enhancement of Anticancer Effects by Combining 5-Fluorouracil with Refametinib in Human Oral Squamous Cell Carcinoma Cell Line
    Chen, Po-Chun
    Su, Bor-Chyuan
    Ma, Tien-Li
    Hong, Ying Chui
    Chen, Yu-Wen
    Vo, Thi Thuy Tien
    Wu, Luo-Yun
    Peng, Tzu-Yu
    Wang, Ching-Shuen
    Lee, I-Ta
    APPLIED SCIENCES-BASEL, 2023, 13 (07):
  • [4] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL
    AMREIN, PC
    WIETZMAN, SA
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) : 1632 - 1639
  • [5] Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma
    Suzuki, Maiko
    Shinohara, Fumiaki
    Nishimura, Kentaro
    Echigo, Seishi
    Rikiishi, Hidemi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (06) : 1449 - 1456
  • [6] The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line
    Johnston, PG
    Geoffrey, F
    Drake, J
    Voeller, D
    Grem, JL
    Allegra, CJ
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (12) : 2148 - 2154
  • [7] Treatment of squamous cell carcinoma with intralesional 5-fluorouracil
    Morse, LG
    Kendrick, C
    Hooper, D
    Ward, H
    Parry, E
    DERMATOLOGIC SURGERY, 2003, 29 (11) : 1150 - 1153
  • [8] Spindle Cell Squamous Cell Carcinoma of the Scalp Treated With Pembrolizumab Cisplatin and 5-Fluorouracil
    Alzahrani, Ali M.
    Al Mutari, Bander
    Alzahrani, Anas
    Alkhodaidi, Abdelhafeeth
    Yahya, Gaaem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [9] Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged
    Cartei, G
    Cartei, F
    Interlandi, G
    Meneghini, G
    Jop, A
    Zingone, G
    Tabaro, G
    Mazzoleni, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (02): : 181 - 184
  • [10] TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN WITH CISPLATIN, 5-FLUOROURACIL, AND BLEOMYCIN
    SADEK, H
    AZLI, N
    WENDLING, JL
    CVITKOVIC, E
    RAHAL, M
    MAMELLE, G
    GUILLAUME, JC
    ARMAND, JP
    AVRIL, MF
    CANCER, 1990, 66 (08) : 1692 - 1696